APTAMER THERAPEUTICS CREATIVE GROUP
Aptamer Therapeutics Creative Group develops novel treatments for infectious diseases, autoimmune diseases, and cancer. Aptamers are a class of molecules that combine the advantages of small molecule drugs and biologics.
APTAMER THERAPEUTICS CREATIVE GROUP
Industry:
Biotechnology Health Care Therapeutics
Address:
Houston, Texas, United States
Country:
United States
Status:
Active
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Angimmune
Angimmune develops immunotherapies for cancer and autoimmune diseases, focusing on anti-T cell therapy.
Argos Therapeutics
Argos Therapeutics develops immunotherapy treatments for cancers, infectious and autoimmune diseases, and transplantation rejection.
Lyonbiopôle
Lyonbiopôle is a global competitiveness cluster focused on the fight against infectious diseases, immune disorders, and cancer.
More informations about "Aptamer Therapeutics Creative Group"
Aptamer Therapeutics Creative Group - Crunchbase
Organization. Aptamer Therapeutics Creative Group . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. ... Aptamer Therapeutics Creative Group …See details»
Aptamer Group
Aptamer Group is a leading provider of custom Optimer discovery and development services. Optimer binders are next-generation aptamers …See details»
Aptamer Therapeutics Creative Group - Drug pipelines, Patents, …
Explore Aptamer Therapeutics Creative Group with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Nervous System Diseases, Technology Platform:Aptamer drug …See details»
The Breakthrough Potential Of Aptamer Therapeutics
The first aptamer therapeutic was approved by the FDA in 2004. From the discovery of a ptamers in 1990, this was a rapid journey to the first therapeutic approval in just 14 years. Considering the average time for drug development, …See details»
Aptamer Therapeutics Creative Group - synapse.patsnap.com
Explore Aptamer Therapeutics Creative Group with its drug pipeline, therapeutic area, technology platform, 2 news. Data. Feature. Plans. Sign Up for Free. Request Demo. Sign Up for Free. …See details»
Aptamer Group - Crunchbase Company Profile
The Aptamer group of companies focuses on the development of aptamer technologies. We develop nucleic acid aptamers for use in research & development, biomarker discovery, diagnostics or therapeutic developments. …See details»
Aptamer Companies – Aptamer Society
Tuesday, March 18, 2025. INSOAP Home. About INSOAP; Executive Committee; Aptamers – the INSOAP JournalSee details»
Therapeutics - Aptamer Group
Optimer ® therapeutics. Optimised for health. Optimer ® binders are increasingly being investigated for use in all phases of drug discovery and development.. In a similar manner to antibody therapeutics, Optimer ® binders can act as …See details»
Aptamer Therapeutics Creative Group, Inc. - Company Profile
Aptamer Therapeutics Creative Group, Inc. Overview. Aptamer Therapeutics Creative Group, Inc. filed as a Domestic For-Profit Corporation in the State of Texas on Friday, August 4, 2023 and …See details»
Aptamer Therapeutics Creative Group - Crunchbase
Organization. Aptamer Therapeutics Creative Group . Connect to CRM . Save . Summary People Signals & News Similar Companies. Similar Companies. Edit Similar Companies Section. …See details»
Minding the gap: Unlocking the therapeutic potential …
Sep 13, 2022 Aptamers are RNAs that can bind proteins directly and modulate protein-protein interactions. Given their therapeutic potential, aptamers would be expected to capture the interest of both scientists and investors. However, …See details»
Therapeutic Aptamers: Evolving to Find their Clinical Niche
We predict that the next two to three years will determine if in vitro generated aptamer-based therapeutics will re-emerge as a valuable therapeutic approach. In particular, C5 aptamer is …See details»
Aptamer-Drug Conjugates Development Service - Creative Biolabs
The aptamer can serve as a non-viral vector to selective deliver these therapeutic gene fragments to target diseased tissues or organs. Aptamer-Drug Conjugates Development Service at …See details»
Aptamers: Cutting edge of cancer therapies - PubMed
Aug 4, 2021 The development of an aptamer-based therapeutic has rapidly progressed following the first two reports in the 1990s, underscoring the advantages of aptamer drugs associated …See details»
Aptamer Development Service - Creative Biolabs
Application Drug Delivery: Because of the generally induce lower immune responses in vivo, aptamers play a role in drug delivery systems, facilitating the specific binding of drugs and …See details»
Aptamer Group signs deal with Flip Gene Therapeutics to support …
15/06/2022. Optimer binders will be developed as a gene switch to enable control of gene therapy expression. Aptamer Group plc (AIM: APTA), the developer of novel Optimer ® binders to …See details»
Aptamers: Cutting edge of cancer therapies - Cell Press
The review highlights the latest advances in the development of aptamer-based therapeutics and underscores their advantages for treatment of cancer. Owing to their unique binding …See details»
The recent blooming of therapeutic aptamers - ScienceDirect
Although therapeutic aptamers have been around since the early 1990s, interest from academia and private investors has lagged behind other RNA-based therapeutics and monoclonal …See details»
Exploring the relationship between aptamer binding …
1 day ago The other outlier is CN-Es2, another estradiol aptamer isolated by the Liu group , which binds its target with ∼33-fold higher affinity (K D = 30 nM) relative to BES.1. This …See details»
Aptamer-Therapeutic Oligonucleotide Conjugates ... - Creative …
Aptamer-Therapeutic Oligonucleotide Conjugates Development Service. The conjugation of aptamers and therapeutic oligonucleotides can be easily achieved by covalent ligation or …See details»